TY - JOUR
KW - Buprenorphine/therapeutic use
KW - COVID-19
KW - Communicable Disease Control
KW - Humans
KW - Mobile applications
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pilot Projects
KW - SARS-CoV-2
KW - smartphone
KW - digital health
KW - Medications for opioid use disorder
KW - Mobile Health
KW - opioid use disorder
AU - J. Hodges
AU - M. Waselewski
AU - W. Harrington
AU - T. Franklin
AU - K. Schorling
AU - J. Huynh
AU - A. Tabackman
AU - K. Otero
AU - K. Ingersoll
AU - N. A. Tiouririne
AU - T. Flickinger
AU - R. Dillingham
A1 - 
AD - Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, Charlottesville, VA, 22908-1340, USA. jchodges03@gmail.com.; University of Michigan Medical School, 7300 Medical Science Building I - A Wing, 1301 Catherine St., Ann Arbor, MI, 48109-5624, USA.; University of Virginia School of Medicine, 1215 Lee St, Charlottesville, VA, 22903, USA.; University of Virginia School of Medicine, 1215 Lee St, Charlottesville, VA, 22903, USA.; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, 1300 Jefferson Park Ave., Charlottesville, VA, 22903, USA.; University of Virginia School of Medicine, 1215 Lee St, Charlottesville, VA, 22903, USA.; University of Virginia School of Medicine, 1215 Lee St, Charlottesville, VA, 22903, USA.; Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, Charlottesville, VA, 22908-1340, USA.; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, 1300 Jefferson Park Ave., Charlottesville, VA, 22903, USA.; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, 1300 Jefferson Park Ave., Charlottesville, VA, 22903, USA.; Department of Medicine, University of Virginia, 1215 Lee St, Charlottesville, VA, 22903, USA.; Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, Charlottesville, VA, 22908-1340, USA.
BT - Addiction science & clinical practice
C5 - HIT & Telehealth; Opioids & Substance Use
CP - 1
DO - 10.1186/s13722-022-00296-4
IS - 1
JF - Addiction science & clinical practice
LA - eng
M1 - Journal Article
PB - . The Author(s)
PY - 2022
SN - 1940-0640; 1940-0632; 1940-0632
SP - 16
T1 - Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown
T2 - Addiction science & clinical practice
TI - Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown
U1 - HIT & Telehealth; Opioids & Substance Use
U2 - 35255965
U3 - 10.1186/s13722-022-00296-4
VL - 17
VO - 1940-0640; 1940-0632; 1940-0632
Y1 - 2022
Y2 - Mar 7
ER -